LLY

1,057.79

-1.63%↓

JNJ

205.59

-0.49%↓

ABBV

224.87

-1.27%↓

UNH

323.52

-1.98%↓

AZN

90.48

-2.43%↓

LLY

1,057.79

-1.63%↓

JNJ

205.59

-0.49%↓

ABBV

224.87

-1.27%↓

UNH

323.52

-1.98%↓

AZN

90.48

-2.43%↓

LLY

1,057.79

-1.63%↓

JNJ

205.59

-0.49%↓

ABBV

224.87

-1.27%↓

UNH

323.52

-1.98%↓

AZN

90.48

-2.43%↓

LLY

1,057.79

-1.63%↓

JNJ

205.59

-0.49%↓

ABBV

224.87

-1.27%↓

UNH

323.52

-1.98%↓

AZN

90.48

-2.43%↓

LLY

1,057.79

-1.63%↓

JNJ

205.59

-0.49%↓

ABBV

224.87

-1.27%↓

UNH

323.52

-1.98%↓

AZN

90.48

-2.43%↓

Home・Elenco Azioni・DaVita Inc

DaVita Inc

Chiusa

SettoreSettore sanitario

119.39 -0.34

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

118.03

Massimo

120.51

Metriche Chiave
By Trading Economics
Entrata	34M 310M
Vendite	41M 3.4B
P/E Media del settore	12.331 79.874
EPS	2.51
Margine di Profitto	9.051
Dipendenti	76,000
EBITDA	-203M 486M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	+14.05% upside

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-719M 8.5B
Apertura precedente	119.73
Chiusura precedente	119.39

Notizie sul Sentiment di mercato

By Acuity

57%

43%

317 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

142.36 / 144.275 Supporto e resistenza

DaVita Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 feb 2025, 19:50 UTC

I principali Market Mover

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 mar 2025, 08:19 UTC

Discorsi di Mercato

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Confronto tra pari

Modifica del prezzo

DaVita Inc Previsione

Obiettivo di Prezzo

By TipRanks

14.05% in crescita

Previsioni per 12 mesi

Media 136.5 USD 14.05%

Alto 143 USD

Basso 130 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per DaVita Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a DaVita Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

142.36 / 144.275Supporto e resistenza

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

317 / 374 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.